Fundz
Real-time · AI · Cross-signal

Kyle Lynch just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Kyle Lynch's next role move, new team, and the deals that follow. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo

Everyone else gives you a piece

Crunchbase & PitchBook list the companyNo person, no timing, no opener.
ZoomInfo & Apollo sell you a contactNo trigger, no reason to reach out now.
LinkedIn Sales Navigator shows you peopleNo real-time signal, no opener.
Clay enriches lists you builtNo live signal of its own, no who or when.
ChatGPT & gen-AI tools answer on a delayNo live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Lumexa Imaging Appoints Kyle Lynch As Chief Growth Officer

PUBLIC · LMRIApr 20, 2026about 2 months ago

Position

Chief Growth Officer

Company

Lumexa Imaging

Kyle Lynch
RaleighManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Lumexa Imaging has announced the appointment of Kyle Lynch as its new Chief Growth Officer, effective immediately. Lynch will focus on driving sustainable and profitable growth through strategic initiatives.

Company Information

Company

Lumexa Imaging

Location

Raleigh, North Carolina, United States

About

Lumexa Imaging is one of the nation’s largest providers of outpatient medical imaging, with a mission to expand access to advanced, high-quality, and affordable diagnostic care. We operate more than 180 centers across 13 states, including more than 85 centers in joint ventures with leading health systems. With over 5,000 team members and a clinical network of more than 1,000 subspecialized radiologists, we perform over 4 million outpatient studies each year. Lumexa Imaging is the partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform. As the healthcare landscape shifts toward more convenient, lower-cost outpatient solutions, Lumexa Imaging is uniquely positioned to meet this growing demand, bringing clarity, comfort, and compassionate care to more patients in more communities.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Lumexa Imaging's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.